# Scentian Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/scentian-bio

- Industry: Biotechnology
- Headquarters: Auckland, New Zealand
- Website: www.scentianbio.com
- Total disclosed funding: $2.1M
- Latest round: Seed (Sep 27, 2023)
- Investors on record: 4

## About

Based in New Zealand, and founded in 2020 by CTO Andrew Rabbit, Scentian Bio Limited operates as a provider of biosensor technology based on insect olfactory receptors (iOR) for the food and health industries. In April 2026, Scentian Bio Limited raised USD 7 million in pre-series A funding led by Icehouse Ventures, with participation from Toyota Ventures, DYDX Capital, K1W1, Booster NZ, Cultivate Ventures, and NZ Growth Capital Partners. As of 2023, Jonathan Good operates as a Chief Executive Officer of Scentian Bio. 

Scentian Bio Limited provides technology by combining insect olfactory receptors with nanotechnology and artificial intelligence for taste and smell solutions for the food and health industries. The company’s technology processes include capturing samples, and odorant receptor arrays, gathering receptor responses through machine learning for diagnostic algorithms, and creating insights. In addition, the firm’s technology provides an interpretation of chemical language created by living organisms. The company will use the April 2026 funding to expand sales to food industry customers, establish manufacturing in Auckland, build sales and support teams, and continue developing a next-generation sensing platform for environmental and health applications.

## Funding rounds

- Seed, Sep 27, 2023, $2.1M — Finistere Ventures, OurCrowd, Icehouse Ventures, Toyota Ventures

## Investors

- Finistere Ventures (https://capitalatlas.ai/funds/finistere-ventures) — Seed
- OurCrowd (https://capitalatlas.ai/funds/ourcrowd) — Seed
- Icehouse Ventures (https://capitalatlas.ai/funds/icehouse-ventures) — Seed
- Toyota Ventures (https://capitalatlas.ai/funds/toyota-ventures) — Seed